These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34756074)

  • 41. Improved correlation between multiple mutations within the NS5A region and virological response in European patients chronically infected with hepatitis C virus type 1b undergoing combination therapy.
    Sarrazin C; Berg T; Lee JH; Teuber G; Dietrich CF; Roth WK; Zeuzem S
    J Hepatol; 1999 Jun; 30(6):1004-13. PubMed ID: 10406177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors.
    Jin G; Lee S; Choi M; Son S; Kim GW; Oh JW; Lee C; Lee K
    Eur J Med Chem; 2014 Mar; 75():413-25. PubMed ID: 24561671
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ultra-deep pyrosequencing (UDPS) data treatment to study amplicon HCV minor variants.
    Gregori J; Esteban JI; Cubero M; Garcia-Cehic D; Perales C; Casillas R; Alvarez-Tejado M; Rodríguez-Frías F; Guardia J; Domingo E; Quer J
    PLoS One; 2013; 8(12):e83361. PubMed ID: 24391758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance assessment of a fully automated deep sequencing platform for HCV resistance testing.
    Rodriguez C; Mercier-Darty M; Soulier A; Poiteau L; Wlassow M; Fourati S; Hézode C; Pawlotsky JM; Chevaliez S
    Antivir Ther; 2019; 24(6):417-423. PubMed ID: 31112134
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantifying the Evolutionary Constraints and Potential of Hepatitis C Virus NS5A Protein.
    Dai L; Du Y; Qi H; Huber CD; Chen D; Zhang TH; Wu NC; Wang E; Lloyd-Smith JO; Sun R
    mSystems; 2021 Apr; 6(2):. PubMed ID: 33850042
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Similarities between Human Immunodeficiency Virus Type 1 and Hepatitis C Virus Genetic and Phenotypic Protease Quasispecies Diversity.
    Martinez MA; Nevot M; Jordan-Paiz A; Franco S
    J Virol; 2015 Oct; 89(19):9758-64. PubMed ID: 26178979
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells.
    Bungyoku Y; Shoji I; Makine T; Adachi T; Hayashida K; Nagano-Fujii M; Ide YH; Deng L; Hotta H
    J Gen Virol; 2009 Jul; 90(Pt 7):1681-1691. PubMed ID: 19282429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell culture-adaptive mutations promote viral protein-protein interactions and morphogenesis of infectious hepatitis C virus.
    Jiang J; Luo G
    J Virol; 2012 Sep; 86(17):8987-97. PubMed ID: 22674987
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for Internal Initiation of RNA Synthesis by the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B
    Schult P; Nattermann M; Lauber C; Seitz S; Lohmann V
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31315989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of hepatitis C virion production via phosphorylation of the NS5A protein.
    Tellinghuisen TL; Foss KL; Treadaway J
    PLoS Pathog; 2008 Mar; 4(3):e1000032. PubMed ID: 18369478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The nonstructural 5A protein of hepatitis C virus genotype 1b does not contain an interferon sensitivity-determining region.
    Brillet R; Penin F; Hezode C; Chouteau P; Dhumeaux D; Pawlotsky JM
    J Infect Dis; 2007 Feb; 195(3):432-41. PubMed ID: 17205483
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Seed sequence-matched controls reveal limitations of small interfering RNA knockdown in functional and structural studies of hepatitis C virus NS5A-MOBKL1B interaction.
    Chung HY; Gu M; Buehler E; MacDonald MR; Rice CM
    J Virol; 2014 Oct; 88(19):11022-33. PubMed ID: 25031347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell culture-adaptive mutations in the NS5B gene of hepatitis C virus with delayed replication and reduced cytotoxicity.
    Kang JI; Kim JP; Wakita T; Ahn BY
    Virus Res; 2009 Sep; 144(1-2):107-16. PubMed ID: 19374927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploring the hepatitis C virus genome using single molecule real-time sequencing.
    Takeda H; Yamashita T; Ueda Y; Sekine A
    World J Gastroenterol; 2019 Aug; 25(32):4661-4672. PubMed ID: 31528092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of Hepatitis C Virus NS5A Region in Patients with Cirrhosis Using an Ultra-Deep Pyrosequencing Method.
    Keskin F; Ciftci S; Akyuz F; Abaci N; Cakiris A; Akyuz U; Demir K; Besisik F; Ustek D; Kaymakoglu S
    Clin Lab; 2017 Sep; 63(9):1439-1445. PubMed ID: 28879707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serine phosphorylation of the hepatitis C virus NS5A protein controls the establishment of replication complexes.
    Ross-Thriepland D; Mankouri J; Harris M
    J Virol; 2015 Mar; 89(6):3123-35. PubMed ID: 25552726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evasion of superinfection exclusion and elimination of primary viral RNA by an adapted strain of hepatitis C virus.
    Webster B; Ott M; Greene WC
    J Virol; 2013 Dec; 87(24):13354-69. PubMed ID: 24089557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencing.
    Abayasingam A; Leung P; Eltahla A; Bull RA; Luciani F; Grebely J; Dore GJ; Applegate T; Page K; Bruneau J; Cox AL; Kim AY; Schinkel J; Shoukry NH; Lauer GM; Maher L; Hellard M; Prins M; Lloyd A; Rodrigo C;
    Infect Genet Evol; 2019 Jul; 71():36-41. PubMed ID: 30853512
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of intergenotypic chimeric replicons to determine the broad-spectrum antiviral activities of hepatitis C virus polymerase inhibitors.
    Herlihy KJ; Graham JP; Kumpf R; Patick AK; Duggal R; Shi ST
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3523-31. PubMed ID: 18694956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative analysis of nearly full-length hepatitis C virus quasispecies from patients experiencing viral breakthrough during antiviral therapy: clustered mutations in three functional genes, E2, NS2, and NS5a.
    Xu Z; Fan X; Xu Y; Di Bisceglie AM
    J Virol; 2008 Oct; 82(19):9417-24. PubMed ID: 18667493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.